$1.77
5.35% yesterday
Nasdaq, Oct 15, 10:13 pm CET
ISIN
US82024L1035
Symbol
STTK

Shattuck Labs Inc Stock price

$1.77
-0.02 1.12% 1M
+0.95 115.96% 6M
+0.56 46.28% YTD
+0.28 18.79% 1Y
-1.29 42.16% 3Y
-17.77 90.94% 5Y
-15.23 89.59% 10Y
-15.23 89.59% 20Y
Nasdaq, Closing price Wed, Oct 15 2025
-0.10 5.35%
ISIN
US82024L1035
Symbol
STTK
Industry

Key metrics

Basic
Market capitalization
$111.8m
Enterprise Value
$61.3m
Net debt
positive
Cash
$50.5m
Shares outstanding
47.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
37.3 | -
EV/Sales
20.4 | -
EV/FCF
negative
P/B
2.0
Financial Health
Equity Ratio
87.5%
Return on Equity
-94.7%
ROCE
-110.1%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$3.0m | $0.0
EBITDA
$-61.2m | $-61.3m
EBIT
$-65.0m | $-56.3m
Net Income
$-61.5m | $-40.4m
Free Cash Flow
$-55.9m
Growth (TTM | estimate)
Revenue
-27.4% | -100.0%
EBITDA
29.3% | 20.0%
EBIT
28.2% | 29.9%
Net Income
27.9% | 46.4%
Free Cash Flow
11.6%
Margin (TTM | estimate)
Gross
-
EBITDA
-2,042.8% | -
EBIT
-2,168.2%
Net
-2,052.5% | -
Free Cash Flow
-1,866.6%
More
EPS
$-1.2
FCF per Share
$-1.2
Short interest
1.3%
Employees
44
Rev per Employee
$130.0k
Show more

Is Shattuck Labs Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Shattuck Labs Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Shattuck Labs Inc forecast:

9x Buy
69%
4x Hold
31%

Analyst Opinions

13 Analysts have issued a Shattuck Labs Inc forecast:

Buy
69%
Hold
31%

Financial data from Shattuck Labs Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
3 3
27% 27%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 18 18
10% 10%
589%
- Research and Development Expense 50 50
33% 33%
1,677%
-61 -61
29% 29%
-2,041%
- Depreciation and Amortization 3.76 3.76
5% 5%
125%
EBIT (Operating Income) EBIT -65 -65
28% 28%
-2,166%
Net Profit -62 -62
28% 28%
-2,050%

In millions USD.

Don't miss a Thing! We will send you all news about Shattuck Labs Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Shattuck Labs Inc Stock News

Neutral
Seeking Alpha
5 days ago
Shattuck Labs, Inc. (NASDAQ:STTK ) The United European Gastroenterology (UEG) Congress UEG Week 2025 October 8, 2025 10:00 AM EDT Company Participants Taylor Schreiber - Co-Founder, CEO & Director Conference Call Participants Yu Fan - Wedbush Securities Inc., Research Division Marla C Dubinsky David De Vries - TR1X, Inc. David Nierengarten - Wedbush Securities Inc., Research Division Conversati...
Neutral
GlobeNewsWire
14 days ago
AUSTIN, TX and DURHAM, NC, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immune-related diseases, today announced that Company management will participate in a panel discussion ...
Neutral
GlobeNewsWire
about 2 months ago
— Aggregate net proceeds from private placement expected to fund SL-325 through multiple Phase 2 clinical trials, including in Inflammatory Bowel Disease (IBD) and potentially another autoimmune disease —
More Shattuck Labs Inc News

Company Profile

Shattuck Labs, Inc. engages in the research and development of Agonist Redirected Checkpoint (ARC) platform. It develops a novel class of biologic medicines, capable of multifunctional activity, with potential applications in oncology and autoimmune diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.

Head office United States
CEO Taylor Schreiber
Employees 44
Founded 2016
Website www.shattucklabs.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today